KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced that the company will be webcasting its corporate presentation at the 2016 Wedbush Pacgrow Healthcare Conference on Tuesday, August 16, 2016 at 2:30 p.m. EDT in New York.
To access the live audio webcast of the presentation, please visit the “Investors” section of the company’s website at www.trevena.com. Following the conclusion of the presentation, the webcast will be archived for 30 days.
To access the live audio webcast of the presentation, please visit the “Investors” section of the company’s website at www.trevena.com. Following the conclusion of the presentation, the webcast will be archived for 30 days.
